On December 27, Gelonghui reported that Hong Kong stock "the first stock in medical imaging services" Yimai Sunshine (2522.HK) closed up 9.11% today at HKD 69.5, hitting a historic high with a total market value of HKD 24.764 billion. Since its listing in June this year, the stock has soared nearly 364%. In terms of news, the recent State Council meeting pointed out the need to deepen the reform of the entire process of Pharmaceutical and medical instruments regulation to better meet the public demand for high-quality Pharmaceutical and medical instruments. There should be increased support for the research and innovation of Pharmaceutical and medical instruments, and active promotion of the use of Innovative Drugs and medical instruments. The quality and efficiency of review and approval should be improved, and the approval and market entry of urgently needed clinical Pharmaceutical and medical instruments should be expedited. Additionally, last month, Yimai Sunshine reached a strategic cooperation with Yinghe Medical and Lianren Health. According to the agreement, the three parties will rely on "shared center + data collection and aggregation + Data Storage and Data Operation" as a starting point for industry implementation. Leveraging their respective advantages, they will support each other with products and channels to jointly build a medical imaging big data center based on a shared center for medical imaging (ECG, pathology, inspection/testing), creating a comprehensive platform that integrates Data Storage, processing, analysis, and application.